In IUGR fetal sheep, pharmaceutical blockade of elevated adrenergic activity via direct fetal infusion of Adrβ/α antagonists yielded immediate recovery of glucose-stimulated insulin secretion (Leos et al., 2010; Macko et al., 2013). The gene discussed is INS; the disease is fetal growth restriction.